Global cannabis market projected to grow at GAGR of 34% to $444 Billion by 2030, from $57 Billion in 2023
CALI, Colombia, April 15, 2024 (GLOBE NEWSWIRE) — Sannabis, Inc. f/k/a Ultimate Sports, Inc. (OTC: USPS) (the ‘Company’), a Men’s Health services provider in the U.S., acquiring Sannabis S.A.S., a fully licensed prominent cannabis company in Colombia, announces the posting of current disclosures on the OTC Markets Group and the commencement of its expansive cannabis cultivation operations in Colombia. Sannabis entered into a contract with licensed growers, like themselves, and has begun the cultivation process to plant seedlings to produce high-quality CBD flower.
Sannabis aims to meet the rising demand for premium cannabis products in the North and South American, European, and Asian markets. They are positioned to be a major player to satisfy the exploding demand for premium cannabis products in the U.S., Europe, and global markets, by ensuring a steady and sustainable production cycle.
According to Fortune Business Insights, the global cannabis market size is projected to grow from $57.18 billion in 2023 to $444.34 billion by 2030, at a CAGR of 34.03% during the forecast period, click here to see highlights of their report.
“Sannabis products currently sold in Colombia are making their way to the U.S. market,” said Juan Pablo Guzmán, Sannabis co-founder and Company Director. “Outsourcing grow operations allows us to focus more on product innovation and distribution to meet the growing global demand for our cannabis flower and derivative products,” continued Mr. Guzmán.
Click here to see a pictures and videos of Sannabis grow operations in Colombia.
Click here to see Pink Current OTC Market disclosures.
For more information about Sannabis and its range of innovative cannabis products, please visit Sannabis.co.
About Sannabis, Inc., f/k/a Ultimate Sports, Inc.
Sannabis, Inc. f/k/a Ultimate Sports, Inc.’s is acquiring Sannabis S.A.S. in Colombia. Their Men’s Advanced RX Online Medical Clinic provides a licensed physician to diagnose and treat male health and wellness issues and is also seeking strategic mergers and acquisitions. They have converted their “brick & mortar” clinics to online telehealth services. Telehealth services are a growing sector of online medical clinics. Visit MensARX.com for more information.
About Sannabis S.A.S.
Sannabis S.A.S. is a fully licensed cannabis company operating in Colombia. They have a line of cosmetic, medical, homeopathic, and industrial products, made from cannabis and hemp. They are licensed to grow, manufacture, and export cannabis and cannabis derivatives. For more information, visit Sannabis.co.
Company/Media/Contact:
John Campo, Investor Relations, Sannabis co-founder
+1-410-236-8200 USA (Office/WhatsApp)
+57-318-657-0918 Colombia (Office)
support@mensarx.com
Sannabis SAS/Media Contact:
Juan Pablo Guzmán, Director, Sannabis co-founder
+57-305-321-1853 Colombia Office
sannabis.sas@gmail.com
Forward Looking Statements
Forward Looking Statements: This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements might not occur. Factors that could cause or contribute to such differences include financing, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations. Sannabis, Inc. f/k/a Ultimate Sports, Inc. and/or Sannabis S.A.S. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
- Dojo Fresh Brings Plant-Based Protein to More Meals With Support From the Non-GMO Project - May 15, 2025
- HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results - May 15, 2025
- Moody’s Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy - May 15, 2025
